Investing
A frequent partner of biopharmas and the FDA, it has raised $94 million from investors since its commercial launch in 2015.
The raise reportedly brings the company's valuation into unicorn territory.
PatientPop says it will use these funds to continue to provide practices with the tools they need to give patients both in-person and online.
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
Also: Klara closes $15 million for digital patient engagement; Trellus Health collects $5 million seed funding and announces exclusive commercialization deal.
The platform recently launched in California, and is eyeing more states down the line.
The company's diabetic foot ulcer detection platform is now available through 40 VA medical centers.
The company formerly known as Fit4D said that it would be using the funds to scale and accelerate market adoption of its virtual coaching and telemedicine services.
The company has established collaborations with several vaccine development companies, including the San Diego-based Arcturus which is running clinical trials in Singapore.